These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4656484)

  • 1. De-Nol for gastric and duodenal ulcers.
    Drug Ther Bull; 1972 Nov; 10(24):95-6. PubMed ID: 4656484
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).
    Baron JH; Barr J; Batten J; Sidebotham R; Spencer J
    Gut; 1986 May; 27(5):486-90. PubMed ID: 3084345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of a bismuth-protein-complex compound in the treatment of gastric and duodenal ulcers.
    Weiss G; Serfontein WJ
    S Afr Med J; 1971 Apr; 45(17):467-70. PubMed ID: 4932258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease].
    Maev IV; Samsonov AA; Golubev NN
    Klin Med (Mosk); 2008; 86(9):57-63. PubMed ID: 19048841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study).
    Patty I; Tárnok F; Simon L; Jávor T; Deák G; Benedek S; Kenéz P; Nagy L; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):379-84. PubMed ID: 6397969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre pilot study of tri-potassium di-citrato bismuthate ('De-Nol') in general practice.
    Cruickshank GW; Wright T
    Curr Med Res Opin; 1973; 1(10):629-34. PubMed ID: 4778728
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Effective treatment of gastric ulceration with a Bismuth preparation (De-Nol).
    Boyes BE; Woolf IL; Wilson RY; Cowley DJ; Dymock IW
    Gut; 1974 Oct; 15(10):833. PubMed ID: 4611754
    [No Abstract]   [Full Text] [Related]  

  • 8. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful bismuth (De-Nol) therapy for gastric ulcer.
    Scobie BA
    N Z Med J; 1976 Sep; 84(571):192-3. PubMed ID: 1070589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind endoscopic study with De-Nol tablets and cimetidine for duodenal ulcer.
    Bianchi Porro G; Petrillo M; De Nicola C; Lazzaroni M
    Scand J Gastroenterol; 1984 Oct; 19(7):905-8. PubMed ID: 6397848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental clinical study with agel-bismuth in the treatment of gastroduodenal lesions].
    Güemes Díaz F; Conesa Picó O; Hidalgo H; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1973 Dec; 41(7):841-52. PubMed ID: 4775610
    [No Abstract]   [Full Text] [Related]  

  • 14. [Protection of the gastric mucosa by prostaglandins--is this physiologic concept suitable for ulcer therapy?].
    Schepp W
    Leber Magen Darm; 1986 Jan; 16(1):41-50. PubMed ID: 3959724
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
    Karateev AE; Nasonov EL; Radenska-Lopovok SG
    Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denol, an effective drug in the therapy of duodenal ulceration.
    Connon JJ
    Ir Med J; 1977 Apr; 70(6):206-7. PubMed ID: 324947
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of the gastric and duodenal ulcer. Clinico-statistical study on the use of a new drug: sulfoglycopeptide].
    Fazzini G; Giampaglia G; Scarpulla P
    Minerva Chir; 1974 Sep; 29(17):933-5. PubMed ID: 4608974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
    Vallot T; Mignon M
    Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.